Peripheral September 24, 2019 TINTIN trial shows impressive results at 6-months. TINTIN trial results Barcelona,… admin
Coronary and peripheral news May 29, 2019 iVascular launches innoVasc, a new open innovation program that tackles the current and future challenges of vascular therapies. New open innovation program… admin
Coronary and peripheral news May 28, 2019 New study in ISR with essential DCB presented at EuroPCR 2019. New study in ISR… admin
Coronary and peripheral news May 23, 2019 EFFPAC RCT 24-month has revealed in EuroPCR 2019 EFFPAC RCT 24-month has… admin
February 20, 2019 Navitian, iVascular´s new coronary microcatheter receives the CE mark approval Barcelona, February 12th, 2019.… admin
November 14, 2018 iVascular completes the enrollment of patients in T.I.N.T.I.N. study Barcelona, November 14th of… admin
October 19, 2018 iVascular acquires 10% of the shares of the American company NaviGate Cardiac Structures, Inc. for 10 million dollars. Sant Vicenç dels Horts… admin
October 4, 2018 iVascular reveals 24 months outcomes of Anchor trial and presents outcomes of two major RCT at TCT 2018. San Diego, September 24th,… admin
October 4, 2018 iVascular demonstrates benefits of leading products at CIRSE 2018 Lisbon, September 23rd, 2018.… admin